This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC) and Boston Scientific (BSX)

Tipranks - Thu Jul 30, 5:26PM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC) and Boston Scientific (BSX).

Claim 55% Off TipRanks

Teladoc (TDOC)

In a report released today, Ryan Daniels from William Blair reiterated a Hold rating on Teladoc. The company’s shares closed last Wednesday at $9.18.

According to TipRanks.com, Daniels is a 4-star analyst with an average return of 5.4% and a 49.2% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Hinge Health, Inc. Class A, Pediatrix Medical Group, and Lifestance Health Group. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Teladoc with a $7.70 average price target, implying a -17.8% downside from current levels. In a report issued on July 24, Citi also maintained a Hold rating on the stock with a $11.00 price target.

See the top stocks recommended by analysts >>

Boston Scientific (BSX)

TD Cowen analyst Josh Jennings maintained a Buy rating on Boston Scientific today and set a price target of $56.00. The company’s shares closed last Wednesday at $46.04.

According to TipRanks.com, Jennings is a 3-star analyst with an average return of 2.2% and a 45.8% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Orchestra BioMed Holdings, and Baxter International. ;'>

Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $68.42, which is a 60.3% upside from current levels. In a report issued on July 14, TipRanks – DeepSeek also upgraded the stock to Buy with a $49.00 price target.

Read More on TDOC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.